Provided By GlobeNewswire
Last update: May 9, 2024
MISSISSAUGA, Ontario, May 09, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2024 on Thursday, May 16, 2024 after market hours. A presentation on the Company’s first quarter 2024 results by René Goehrum, BioSyent President and CEO, will also be available on the Company’s website on the date of release.
Read more at globenewswire.com